Necroptosis: a potential, promising target and switch in acute pancreatitis

Apoptosis. 2016 Feb;21(2):121-9. doi: 10.1007/s10495-015-1192-3.

Abstract

Pancreatic acinar cell death is the major pathophysiological change in early acute pancreatitis (AP), and the death modalities are important factors determining its progression and prognosis. During AP, acinar cells undergo two major modes of death, including necrosis and apoptosis. Acinar necrosis can lead to intensely local and systemic inflammatory responses, which both induce and aggravate the lesion. Necrosis has long been considered an unregulated, and passive cell death process. Since the effective interventions of necrosis are difficult to perform, its relevant studies have not received adequate attention. Necroptosis is a newly discovered cell death modality characterized by both necrosis and apoptosis, i.e., it is actively regulated by special genes, while has the typical morphological features of necrosis. Currently, necroptosis is gradually becoming an important topic in the fields of inflammatory diseases. The preliminary results from necroptosis in AP have confirmed the existence of acinar cell necroptosis, which may be a potential target for effectively regulating inflammatory injuries and improving its outcomes; however, the functional changes and mechanisms of necroptosis still require further investigation. This article reviewed the progress of necroptosis in AP to provide a reference for deeply understanding the pathogenic mechanisms of AP and identifying new therapeutic targets.

Keywords: Acute pancreatitis; Damage-associated molecular patterns; Endoplasmic reticulum stress; Inflammasome; Necroptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acinar Cells / physiology
  • Animals
  • Apoptosis*
  • Humans
  • Inflammasomes / physiology
  • Molecular Targeted Therapy
  • Necrosis
  • Pancreas / pathology*
  • Pancreatitis, Acute Necrotizing / drug therapy
  • Pancreatitis, Acute Necrotizing / pathology*
  • Signal Transduction

Substances

  • Inflammasomes